Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth G Saag

Showing results (261-270 of 374) with videos related to

Pageof 38
Sort By:
Arthritis Care & Research|May 11, 2021
Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID-19 Pandemic in a Community Practice-Based NetworkMichael D George, Maria I Danila, Daniel Watrous, et al.
Arthritis Care & Research|May 5, 2012
Physicians' explanations for apparent gaps in the quality of rheumatology care: results from the US Medicare Physician Quality Reporting SystemJeffrey R Curtis, Pradeep Sharma, Tarun Arora, et al.
Arthritis Research & Therapy|September 22, 2011
Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritisJeffrey R Curtis, John W Baddley, Shuo Yang, et al.
Arthritis Care & Research|September 10, 2014
Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapyHuifeng Yun, Fenglong Xie, Elizabeth Delzell, et al.
Annals of the Rheumatic Diseases|March 11, 2014
Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapyHuifeng Yun, Fenglong Xie, Elizabeth Delzell, et al.
Arthritis and Rheumatism|December 1, 2007
Racial/ethnic disparities in patient-reported nonsteroidal antiinflammatory drug (NSAID) risk awareness, patient-doctor NSAID risk communication, and NSAID risk behaviorRachel B Fry, Midge N Ray, Daniel J Cobaugh, et al.
Archives of Osteoporosis|May 28, 2016
The National Osteoporosis Foundation's methods and processes for developing position statementsTaylor C Wallace, Douglas C Bauer, Robert F Gagel, et al.
Pharmacoepidemiology and Drug Safety|January 30, 2013
Association between anti-TNF-α therapy and interstitial lung diseaseLisa J Herrinton, Leslie R Harrold, Liyan Liu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 19, 2021
A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout FlaresKenneth G Saag, Puja P Khanna, Robert T Keenan, et al.
Rheumatology (Oxford, England)|October 11, 2022
Nationwide racial/ethnic disparities in US emergency department visits and hospitalizations for goutChio Yokose, Natalie McCormick, Na Lu, et al.
Pageof 38

Showing results (261-270 of 374) with videos related to

Sort By:
Pageof 38
Arthritis Care & Research|May 11, 2021
Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID-19 Pandemic in a Community Practice-Based NetworkMichael D George, Maria I Danila, Daniel Watrous, et al.
Arthritis Care & Research|May 5, 2012
Physicians' explanations for apparent gaps in the quality of rheumatology care: results from the US Medicare Physician Quality Reporting SystemJeffrey R Curtis, Pradeep Sharma, Tarun Arora, et al.
Arthritis Research & Therapy|September 22, 2011
Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritisJeffrey R Curtis, John W Baddley, Shuo Yang, et al.
Arthritis Care & Research|September 10, 2014
Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapyHuifeng Yun, Fenglong Xie, Elizabeth Delzell, et al.
Annals of the Rheumatic Diseases|March 11, 2014
Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapyHuifeng Yun, Fenglong Xie, Elizabeth Delzell, et al.
Arthritis and Rheumatism|December 1, 2007
Racial/ethnic disparities in patient-reported nonsteroidal antiinflammatory drug (NSAID) risk awareness, patient-doctor NSAID risk communication, and NSAID risk behaviorRachel B Fry, Midge N Ray, Daniel J Cobaugh, et al.
Archives of Osteoporosis|May 28, 2016
The National Osteoporosis Foundation's methods and processes for developing position statementsTaylor C Wallace, Douglas C Bauer, Robert F Gagel, et al.
Pharmacoepidemiology and Drug Safety|January 30, 2013
Association between anti-TNF-α therapy and interstitial lung diseaseLisa J Herrinton, Leslie R Harrold, Liyan Liu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 19, 2021
A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout FlaresKenneth G Saag, Puja P Khanna, Robert T Keenan, et al.
Rheumatology (Oxford, England)|October 11, 2022
Nationwide racial/ethnic disparities in US emergency department visits and hospitalizations for goutChio Yokose, Natalie McCormick, Na Lu, et al.
Pageof 38